$1.62
▼ -0.0% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
Nyxoah Shares Jump After Genio Meets Primary Endpoints in CCC Patient Study
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating
Overview
52-week range
$1.26
$6.88
6% of range
Avg surprise (last 3)
-3.3%
Avg reaction (last 2)
-1.5%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.43 | $-0.54 | +20.4% | +31.8% | -7.8% | earnings |
| Mon Aug 18, 2025 | Jun/2025 | $-0.63 | $-0.62 | -1.6% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.63 | $-0.49 | -28.6% | — | +4.8% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for NYXH.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.